All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.


 Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal counter acting agent used to treat breast cancer and stomach cancer. It is explicitly utilized for cancer that is HER2 receptor positive. It might be utilized without anyone else or along with other chemotherapy drug. Trastuzumab is utilized to treat metastatic (spread) breast cancer. As a major aspect of chemotherapy routine for adjuvant treatment of lymph-hub positive, HER2/neu protein positive breast cancer. Treatment of gastric (stomach) cancer. Trastuzumab is a focused on cancer sedate and is additionally known by its image name, Herceptin, Herzuma and Ontruzant. It is a treatment for cancers that have a lot of a protein called human epidermal development factor receptor 2 (HER2, for example, early breast cancer. propelled breast cancer.

High Impact List of Articles

Relevant Topics in General Science

Google Scholar citation report
Citations : 627

Research & Reviews in BioSciences received 627 citations as per Google Scholar report

Indexed In

  • Google Scholar
  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Scholarsteer
  • Secret Search Engine Labs
  • Euro Pub

View More